Serva Energy is a nuclear technology company revolutionizing the way radioisotopes and nuclear fuels are produced — serving the world critical cancer treatments and a safe carbon-free transition to a clean energy future.
One year ago, through our fuel innovations, we began developing new methods for producing a rare, life-saving radioisotope, Actinium-225, to support pharmaceutical companies in developing novel cancer treatments.
FUEL FOR A NEW AGE
Serva fuel technologies are poised to transform the state of nuclear power within this decade — making reactors safer and
more efficient — while advancing the supply of radioisotopes for health care applications and biomedical research.
A NOVEL PERSPECTIVE
TURNING WASTE INTO
After decades of viewing nuclear waste as a problem to be managed, we see it as an asset to be harnessed — a tool to improve the inherent properties of a nuclear reactor.
Our approach allows for massive amounts of transuranic waste to be transformed into nuclear fuel — fuel that will destroy itself as it generates power.
We take the same approach with Radium-226. Previously considered waste and highly restricted, Ra-226 is now being transformed into the drugs of tomorrow.
SMART NUCLEAR MATERIALS
CREATING NEW REACTIONS
Through our suite of Smart Nuclear Materials, we are able to change reactions that occur in nuclear reactors in powerful ways — allowing for greater reactivity control, safety and sustainability.
We are fundamentally changing the way fission is done in the reactor through a hybrid fission-fusion process.